Cite
HARVARD Citation
Aristei, C. et al. (n.d.). PV-0367 TMLI-based low-toxic myeloablative conditioning regimen in haploidentical HSCT for AML. Radiotherapy and oncology. pp. S182-S183. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aristei, C. et al. (n.d.). PV-0367 TMLI-based low-toxic myeloablative conditioning regimen in haploidentical HSCT for AML. Radiotherapy and oncology. pp. S182-S183. [Online].